VIDAMED INC
8-A12G/A, EX-4.1, 2000-10-30
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: VIDAMED INC, 8-A12G/A, 2000-10-30
Next: PAINEWEBBER PACE SELECT ADVISORS TRUST, 24F-2NT, 2000-10-30



<PAGE>

                                                                     EXHIBIT 4.1

                               AMENDMENT NO. 1 TO
                       PREFERRED SHARES RIGHTS AGREEMENT

     This Amendment No. 1 to Preferred Shares Rights Agreement (this
"Amendment") is between VidaMed, Inc., a Delaware corporation (the "Company"),
and American Securities Transfer & Trust, Inc. (the "Rights Agent"), effective
as of January 3, 2000.

     A.   The Company and the Rights Agent have entered into a Preferred Shares
Rights Agreement, dated as of January 27, 1997 (the "Rights Agreement").
Capitalized terms used and not otherwise defined herein will have the meaning
given in the Rights Agreement.

     B.   Section 27 of the Rights Agreement provides that, prior to the
Distribution Date, the Company may amend the Rights Agreement, including the
definition of an Acquiring Person as set forth in Section 1(a) thereof, and
that, upon any such amendment, the Rights Agent shall amend the Rights Agreement
as the Company directs.

     C.   The Company desires, and hereby directs the Rights Agent, to amend the
definition of an Acquiring Person, and the Rights Agent agrees to such
amendment, on the terms and conditions hereof.

     NOW, THEREFORE, the Company and the Rights Agent agree as follows:

1.   Representations and Warranties.  The Company represents and warrants to the
     ------------------------------
     Rights Agent that:

     (a)  to the best knowledge of the Company, the Distribution Date has not
     occurred prior to the effective date hereof; and

     (b)  this Amendment is authorized pursuant to the requirements of Section
     27 of the Rights Agreement.

2.   Amendment of Section 1(a).  Section 1(a) of the Rights Agreement is hereby
     -------------------------
     amended by deleting Section 1(a) in its entirety and substituting the
     following therefor:

          (a)  "Acquiring Person" shall mean any Person who or which, together
     with all Affiliates and Associates of such Person, shall be the Beneficial
     Owner of 20% or more of the Common Shares then outstanding (the "Acquiring
     Person Triggering Amount"), but shall not include the Company, any
     Subsidiary of the Company or any employee benefit plan of the Company or of
     any Subsidiary of the Company, or any entity holding Common Shares for or
     pursuant to the terms of any such plan.  Notwithstanding the foregoing, no
     Person shall be deemed to be an Acquiring Person as the result of an
     acquisition of Common Shares by the Company which, by reducing the number
     of shares outstanding, increases the proportionate number of shares
     beneficially owned by such Person to the Acquiring Person Triggering
     Amount; provided, however, that if a Person shall become the Beneficial
     Owner of the Acquiring Person Triggering Amount by reason of share
     purchases by the Company and shall, after such share purchases by the
     Company, become the Beneficial Owner of any additional Common Shares of the
<PAGE>

     Company (other than pursuant to a dividend or distribution paid or made by
     the Company on the outstanding Common Shares in Common Shares or pursuant
     to a split or subdivision of the outstanding Common Shares), then such
     Person shall be deemed to be an Acquiring Person unless upon becoming the
     Beneficial Owner of such additional Common Shares of the Company such
     Person does not beneficially own the Acquiring Person Triggering Amount.
     Notwithstanding the foregoing, (i) if a majority of the Continuing
     Directors then in office determines in good faith that a Person who would
     otherwise be an "Acquiring Person," as defined pursuant to the provisions
     of this paragraph (a), has become such inadvertently (including, without
     limitation, because (A) such Person was unaware that it beneficially owned
     a percentage of the Common Shares that would otherwise cause such Person to
     be an "Acquiring Person," as defined pursuant to the provisions of this
     paragraph (a), or (B) such Person was aware of the extent of the Common
     Shares it beneficially owned but had no actual knowledge of the
     consequences of such beneficial ownership under this Agreement) and without
     any intention of changing or influencing control of the Company, and if
     such Person divested or divests as promptly as practicable a sufficient
     number of Common Shares so that such Person would no longer be an
     "Acquiring Person," as defined pursuant to the provisions of this paragraph
     (a), then such Person shall not be deemed to be or to have become an
     "Acquiring Person" for any purposes of this Agreement; and (ii) if, as of
     the date hereof, any Person is the Beneficial Owner of 20% or more of the
     Common Shares outstanding, such Person shall not be or become an "Acquiring
     Person," as defined pursuant to the provisions of this paragraph (a),
     unless and until such time as such Person shall become the Beneficial Owner
     of additional Common Shares (other than pursuant to a dividend or
     distribution paid or made by the Company on the outstanding Common Shares
     in Common Shares or pursuant to a split or subdivision of the outstanding
     Common Shares), unless, upon becoming the Beneficial Owner of such
     additional Common Shares, such Person is not then the Beneficial Owner of
     the Acquiring Person Trigger Amount.  For purposes of this definition of
     "Acquiring Person", the Acquiring Person Trigger Amount for Medtronic Asset
     Management, Inc. or any of its Affiliates or Associates (collectively, the
     "Medtronic Group") shall be 25.0% or more of the Common Shares then
     outstanding (the "Medtronic Trigger Amount") which shall be applicable if
     any member of the Medtronic Group has, or, together with any Affiliates and
     Associates of Medtronic, shall be the Beneficial Owner of, such Medtronic
     Trigger Amount.

3.   No Other Changes.  Except as specifically amended by this Amendment, all
     ----------------
     other provisions of the Rights Agreement shall remain in full force and
     effect.  This Amendment shall not constitute or operate as a waiver of, or
     estoppel with respect to, any provisions of the Rights Agreement by any
     party hereto.

4.   Counterparts.  This Amendment may be executed in one or more counterparts,
     ------------
     each of which shall be deemed an original, but all of which together shall
     constitute one and the same agreement.
<PAGE>

     The Company and the Rights Agent have caused this Amendment to be duly
executed on their behalf by their respective duly authorized representatives as
of the date first written above.





VIDAMED, INC.                         AMERICAN SECURITIES TRANSFER &
                                      TRUST, INC.

By: /s/ Randy D. Lindholm             By: /s/   Laura Sasneros
    -------------------------            ------------------------------------
Its: President & CEO                  Its:      Vice President Trust Officer
     ------------------------              -----------------------------------

                                      AMERICAN SECURITIES TRANSFER &
                                      TRUST, INC.

                                      By: /s/   Kellie Gwinn
                                          ----------------------------------
                                      Its:__________________________________




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission